Efficacy of Remote Ischemic Preconditioning as Non Pharmacologic Strategy to Prevent Contrast Induced Nephropathy (PAIR)

• Status: Withdrawn
• Trial end date: 2018-10-09
• Target enrollment: 0
• Participant gender: All

Summary

This study evaluates remote ischemic preconditioning as an strategy to avoid contrast induced nephropathy. All of the patients will receive endovenous normal saline to prevent nephropathy, half of the patients will receive remote ischemic preconditioning while the other half will not.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Camilo Andrés Páez Angarita

Criteria

Inclusion Criteria:

• Hospitalized in general wards, emergency room or ambulatory consult.

• 18 years or older.

• Requires computerized tomography with endovenous contrast.

• Glomerular filtration rate between 30 - 60 mL/minute/1,73 m2.

• Patient accepts and signs informed consent.

Exclusion Criteria:

• Allergic to contrast media.

• Unable to accept or sign informed consent.

• Did not received endovenous saline before and/or after the contrast procedure.

• Peripheral arterial disease.

• Bilateral upper extremities lymph node dissection or any situation impending arterial pressure taking.

• Morbid obesity (body mass index 40 or more).

• Arterial systolic pressure greater than 175 mmHg.